Stay updated on ENABLE Study: Lanadelumab in HAE Clinical Trial
Sign up to get notified when there's something new on the ENABLE Study: Lanadelumab in HAE Clinical Trial page.

Latest updates to the ENABLE Study: Lanadelumab in HAE Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe Study Record Versions now show a new Revision: v3.3.2 and the removal of Revision: v3.2.0.SummaryDifference0.1%

- Check28 days agoChange DetectedDeleted the government funding and operating status notice directing users to cc.nih.gov and opm.gov.SummaryDifference0.7%

- Check42 days agoChange Detected- Added a new version entry dated 2025-08-29 to the Record History, reflecting updated study status and related sections.SummaryDifference0.1%

- Check71 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference12%

- Check78 days agoChange DetectedUpdated the page from revision v3.0.2 to v3.1.0, signaling a new release version.SummaryDifference0.3%

- Check93 days agoChange DetectedUpdated revision from v3.0.1 to v3.0.2, and removed the Back to Top element. No core content, pricing, stock, or schedule information was affected.SummaryDifference0.7%

Stay in the know with updates to ENABLE Study: Lanadelumab in HAE Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ENABLE Study: Lanadelumab in HAE Clinical Trial page.